Shares of Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report) hit a new 52-week low during mid-day trading on Monday . The company traded as low as GBX 12 ($0.15) and last traded at GBX 13 ($0.16), with a volume of 24529 shares. The stock had previously closed at GBX 12.86 ($0.16).
Celadon Pharmaceuticals Stock Performance
The business has a 50 day simple moving average of GBX 27.40 and a two-hundred day simple moving average of GBX 51.19. The firm has a market cap of £8.74 million, a PE ratio of -158.75 and a beta of -0.26. The company has a quick ratio of 6.97, a current ratio of 1.92 and a debt-to-equity ratio of 194.82.
Celadon Pharmaceuticals Company Profile
Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.
Further Reading
- Five stocks we like better than Celadon Pharmaceuticals
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- CD Calculator: Certificate of Deposit Calculator
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Best Aerospace Stocks Investing
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
